Literature DB >> 23537434

Oxidative-stress-induced epigenetic changes in chronic diabetic complications.

Biao Feng1, Michael Anthony Ruiz, Subrata Chakrabarti.   

Abstract

Oxidative stress plays an important role in the development and progression of chronic diabetic complications. Diabetes causes mitochondrial superoxide overproduction in the endothelial cells of both large and small vessels. This increased superoxide production causes the activation of several signal pathways involved in the pathogenesis of chronic complications. In particular, endothelial cells are major targets of glucose-induced oxidative damage in the target organs. Oxidative stress activates cellular signaling pathways and transcription factors in endothelial cells including protein kinase C (PKC), c-Jun-N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK), forkhead box O (FOXO), and nuclear factor kappa-B (NF-κB). Oxidative stress also causes DNA damage and activates DNA nucleotide excision repair enzymes including the excision repair cross complimenting 1(ERCC1), ERCC4, and poly(ADP-ribose) polymerase (PARP). Augmented production of histone acetyltransferase p300, and alterations of histone deacetylases, including class III deacetylases sirtuins, are also involved in this process. Recent research has found that small noncoding RNAs, like microRNA, are a new kind of regulator associated with chronic diabetic complications. There are extensive and complicated interactions and among these molecules. The purpose of this review is to demonstrate the role of oxidative stress in the development of diabetic complications in relation to epigenetic changes such as acetylation and microRNA alterations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23537434     DOI: 10.1139/cjpp-2012-0251

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  20 in total

1.  Methylation of insulin DNA in response to proinflammatory cytokines during the progression of autoimmune diabetes in NOD mice.

Authors:  Jinxiu Rui; Songyan Deng; Jasmin Lebastchi; Pamela L Clark; Sahar Usmani-Brown; Kevan C Herold
Journal:  Diabetologia       Date:  2016-02-24       Impact factor: 10.122

Review 2.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.

Authors:  Britta Kunkemoeller; Themis R Kyriakides
Journal:  Antioxid Redox Signal       Date:  2017-08-10       Impact factor: 8.401

3.  Promoter DNA demethylation of Keap1 gene in diabetic cardiomyopathy.

Authors:  Zhong-Zhi Liu; Xiang-Zhi Zhao; Xue-Song Zhang; Mei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats.

Authors:  Carol A Everson; Christopher J Henchen; Aniko Szabo; Neil Hogg
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

Review 5.  Mechanistic insights into the role of FOXO in diabetic retinopathy.

Authors:  Tapan Behl; Muskan Wadhwa; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harrasi; Lotfi Aleya; Simona Bungau
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 6.  Significance of epigenetic landscape in cartilage regeneration from the cartilage development and pathology perspective.

Authors:  Jingting Li; James Ohliger; Ming Pei
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

Review 7.  Epigenetics and Cardiovascular Disease in Diabetes.

Authors:  Jennifer Pasquier; Jessica Hoarau-Véchot; Khalid Fakhro; Arash Rafii; Charbel Abi Khalil
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 8.  Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy.

Authors:  Renu A Kowluru; Anjan Kowluru; Manish Mishra; Binit Kumar
Journal:  Prog Retin Eye Res       Date:  2015-05-12       Impact factor: 21.198

Review 9.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14

10.  High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.

Authors:  Antoinette Bugyei-Twum; Andrew Advani; Suzanne L Advani; Yuan Zhang; Kerri Thai; Darren J Kelly; Kim A Connelly
Journal:  Cardiovasc Diabetol       Date:  2014-05-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.